MedTrace Logo

Measuring Cholesterol in the Fasting and Postmeal State in Patients With Type 2 Diabetes

NCT00287404 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2007-12-28

No results posted yet for this study

Summary

Many patients with type 2 diabetes have difficulty attaining cholesterol goals, partly due to the recommendations for fasting measurements that may not be practical in the typical clinical setting. Focus toward therapy is shifting toward non-fasting assessments but little is known about the usefulness of this approach in diabetes, where postmeal cholesterol levels are more abnormal. This is an observational study examining fasting and postmeal lipids (cholesterol) in patients with type 2 diabetes using standard means and NMR.

Conditions

Sponsors & Collaborators

  • LipoScience, Inc.

    collaborator INDUSTRY

  • University of North Carolina

    lead OTHER

Principal Investigators

  • John Buse, MD, PhD · University of North Carolina, Chapel Hill

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Completion
2006-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00287404 on ClinicalTrials.gov